We are live on ! Find out more
BNTC icon

Benitec Biopharma
BNTC

88 hedge funds and large institutions have $346M invested in Benitec Biopharma in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 35 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 8

169% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 13

22% more funds holding

Funds holding: 72 → 88 (+16)

1.05% more ownership

Funds ownership: 93.5% → 94.55% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

19% less capital invested

Capital invested by funds: $427M → $346M (-$80.5M)

Holders
88
Holders Change
+16
Holders Change %
+22.22%
% of All Funds
1.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
35
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SAM
Simplify Asset Management
Nevada
+$4.76M
2
NCM
Nantahala Capital Management
Connecticut
+$4.63M
3
BlackRock
BlackRock
New York
+$2.24M
4
Franklin Resources
Franklin Resources
California
+$2.09M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
SL
Siren LLC
Connecticut
-$10.4M
2
LP
Longaeva Partners
Illinois
-$1.91M
3
WP
Woodline Partners
California
-$1.36M
4
SSA
Schonfeld Strategic Advisors
New York
-$1.26M
5
AIC
AWM Investment Company
New York
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
26
Longaeva Partners
Illinois
$1.33M -$1.91M -165,000 -57%
Russell Investments Group
27
Russell Investments Group
United Kingdom
$1.24M +$1.27M +109,972 +1,769%
UBS Group
28
UBS Group
Switzerland
$1.23M +$202K +17,472 +18%
VPM
29
Vanguard Portfolio Management
Pennsylvania
$1.22M +$1.33M +114,746 New
Marshall Wace
30
Marshall Wace
United Kingdom
$765K +$418K +36,144 +101%
LPC
31
Lion Point Capital
New York
$660K – – –
Charles Schwab
32
Charles Schwab
California
$654K +$187K +16,137 +36%
AI
33
Atom Investors
Texas
$559K +$607K +52,463 New
CF
34
Cantor Fitzgerald
New York
$497K +$540K +46,659 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$463K +$138K +11,877 +38%
N
36
Nuveen
North Carolina
$445K +$267K +23,035 +123%
EAM
37
Empery Asset Management
New York
$324K -$289K -25,000 -45%
Morgan Stanley
38
Morgan Stanley
New York
$312K -$342K -29,542 -50%
EC
39
EntryPoint Capital
New York
$259K +$282K +24,322 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$218K +$32.2K +2,777 +16%
Deutsche Bank
41
Deutsche Bank
Germany
$214K +$90.3K +7,795 +63%
PAP
42
Persistent Asset Partners
Hong Kong
$195K -$28.3K -2,446 -12%
QC
43
Quadrature Capital
United Kingdom
$193K -$155K -13,396 -43%
ACM
44
ADAR1 Capital Management
Texas
$186K +$203K +17,500 New
Bank of America
45
Bank of America
North Carolina
$185K +$60.8K +5,251 +43%
Canada Pension Plan Investment Board
46
Canada Pension Plan Investment Board
Ontario, Canada
$183K +$199K +17,200 New
BHCM
47
Brevan Howard Capital Management
Jersey
$177K +$192K +16,610 New
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$127K +$138K +11,908 New
Creative Planning
49
Creative Planning
Kansas
$123K +$134K +11,586 New
MIM
50
MetLife Investment Management
New Jersey
$100K – – –
1
2
3 4

BNTC Hedge Fund Activity: Q1 2026 in Review

88 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma (BNTC) for Q1 2026, worth a combined $346M — down 19% from $427M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BNTC positions and 8 closed out — a net gain of 17 holders — while 35 added to existing stakes and 13 trimmed.

The largest buyer was Simplify Asset Management, adding an estimated $4.76M. The largest seller was Siren LLC, exiting entirely with an estimated $10.4M sold.

  • 88 institutional investors held Benitec Biopharma (BNTC) as of Q1 2026, up from 72 in Q4 2025.
  • Funds reported $346M of Benitec Biopharma stock for Q1 2026, down 19% quarter-over-quarter.
  • 25 funds opened new Benitec Biopharma positions in Q1 2026 and 8 closed out, a net change of +17 holders.
  • The largest Benitec Biopharma buyer in Q1 2026 was Simplify Asset Management, an estimated $4.76M added.
  • The largest Benitec Biopharma seller in Q1 2026 was Siren LLC, an estimated $10.4M sold.

Based on aggregated 13F filings for Q1 2026.